Cantor Fitzgerald Maintains Neutral on Pfizer, Raises Price Target to $28

Benzinga Newsdesk www.benzinga.com Positive 50.1%

Neg 0% Neu 0% Pos 50.1%

Cantor Fitzgerald analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $27 to $28.